Merck and Ridgeback’s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19 December 23, 2021 by Businesswire [#item_full_content] Related Spread the word
